http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
최흥재 ( Heung Jai Choi ),허갑범 ( Kap Bum Huh ),정진각 ( Chin Kak Chung ),박정호 ( Jung Ho Park ),박봉구 ( Bong Koo Park ) 대한내과학회 1969 대한내과학회지 Vol.12 No.4
A case of choleduodenal fistula caused by duodenal ulcer is reported. A 19 year-old high school boy was hospitalized because of 2 months intermittent postprandial epigastric pain and vomiting which became more severe 1 week prior to the admission. Physical
최흥재(Heung Jai Choi),권혁문(Hyuck Moon Kwon),김병철(Byung Chul Kim),김경희(Kyung Hee Kim),문영명(Young Myung Moon),강진경(Jin Kyung Kang) 대한내과학회 1989 대한내과학회지 Vol.36 No.2
N/A Monoclonal antibody technology using the procedure of hybridization has giveen new hope for developing improved methods to define and quantify tumor markers by Kohler et al. Monoclonal antibodies with reported specificity for several major classes of tumors have been developed, such as 1116 NS19-9 (CA19-9) prepared by Koprowski et al and OC125 (CA125) prepar- ed by Bast et al. The usefulness of the serum ferritin as a tumor marker was reported by Alpert et al. The serum levels of tumor markers (AFP, CEA, CA19-9, CA125, and ferritin) were examined in 100 patients with digestive cancer, in 45 patients with corresponding benign conditions of the digestive system, in 5 patients with other malignancies and in 20 normal persons. The authors evaluated the sensitivity and specificity of each tumor marker and their combinations. The following results were obtained: 1) There were significant differences in concentrations and sensitivities of AFP in patients with hepatoma, and CEA in patients with gastric, colorectal, pancreatic cancer and cholangiocarcinoma, as compared with normal healthy persons, patients with benign liver disease (chronic hepatitis, liver cirrhosis) and patients with corresponding benign conditions of the digestive system (p<0.05). There were also significant differences in concentration and sensitivity of ferritin between patients with hepatoma and benign liver disease (p<0.025). There was a detectable increase in the CA125 serum level and sensitivity in patients with hepatobiliary malignancy but this was of low specificity due to benign conditions involving the hepatobiliary system. 2) In digestive cancers with metastasis, the serum levels and sensitivity of CEA, CA19-9, CA125 and ferritin increased significantly compared with localized cancers (p<0.005). 3) The most excellent combinations for elevating sensitivity were CEA, CA19-9 and CEA CA19-9 ferritin for stomach cancer, AFP CA125 or AFP ferritin and AFP CA125 ferritin for hepatoma, CEA CA19-9 and CEA CA19-9 CA125 for pancreatic cancer and CEA CA19-9 for cholangiocarcinoma, but no combination could elevate the specificity. In colorectal cancer, CEA was the only significant tumor marker.
간경변증에 있어서 초음파검사상 문맥의 크기와 간정맥 계압의 상관관계에 관한 연구
최흥재(Heung Jai Choi),박인서(In Suh Park),문영명(Young Myong Moon),전재윤(Chae Yoon Chon),김두식(Doo Sik Kim),정재복(Jae Bok Chung) 대한소화기학회 1985 대한소화기학회지 Vol.17 No.1
N/A Diagnosis of portal hypertension can be made clinically by observing the esophageal varices, splenomegaly and/or ascites, but it is impossible in case without such clinical finding. For the measurement of portal pressure, wedged hepatic venous pressure, splenic pulp pressure, umblical vein pressure, mesentic vein pressure and direct punture of portal vein at laparotomy have been used, but these methods have not been frequently applied because their procedures are complicated and risky. After introduction of ultrasound in the field of clinical medicine, the portal vein size is easily visualized and the diagnosis of portal hypertension has been made by observing the portal venous system without difficulty. But the normal size of portal and splenic veins which are very important diagnostic criteria in ultrasound examination are not clearly defined and the diagnostic rate by the size of portal and splenic veins are reported by several authors with variable results. In this study we measured the diameter of splenic and portal vein with realtime ultrasonography in inspiratory and expiratory phase and checked the wedged hepatic venous pressure in 29 patients with liver cirrhosis and 14 persons without liver diease for control to see the normal range of diameter of vessels and the relationship between portal pressure and size of vessels. The results are as follows: l) The means of the diameter of splenic and portal veins of 14 control persons in inspira- tory phase were 0.49+-0.166cm and 0.79+-0.209cm and in expiratory phase 0.37% +-0.127cm and 0.67+-0.181cm respectively. The mean wedged hepatic venous pressure in control was 2. 1<1. 013 mmHg. 2) The means of the diameter of splenic and portal vein of 29 patients with liver cirrhosis in inspiration were 1.04+-0.233 cm and 1.30+-0.220 cm and expiration 0.96+-0.281 and 1.21+-0.231cm respectively. The mean wedged hepatic venous pressure in patients group was 14.0+-8.19 mmHg. 3) The upper criteria of normal diameter(mean+2SD) of splenic vein were 0.8cm in inspiration and 0.6 cm in expiration and of portal vein l. 2 cm in inspiration and 1. 0 cm in expiration. The splenic vein was within normal criteria in 13 out of 14 normaI persons in inspiration and expiration. The portal vein was in normal criteria in all in inspiration and in 13 in expiration. 4) In liver cirrhosis the wedged hepatic venous pressure was high (over 5 mmHg) in 24 cases and within normal limits in 5 cases. The size of splenic vein was larger than normal criteria in 2 cases from 5 with normal wedged hepatic venous pressure in inspiration and expiration and in 19 cases from 24 with high wedged hepatic venous pressure in inspiration and 22 cases in expiration. The size of portal vein was larger than normal criteria in 2 cases from 5 with normal wedged hepatic venous pressure in inspiration and 4 in expiration, and 17 cases from 24 with high wedged hepatic venous pressure in inspiration, and 21 cases in expiration, 5) The diagnostic efficacy of size of vessels on ultrasonography for portal hypertension was as follows. The sensitivity of splenic vein was 79.2% In inspihatory phase and 91.7% in expiratory phase and that of portal vein was 70.8% in inspiratory phase and 89.5 in expitatory phase. The specificity of splenic vein was 84.2% in inspiratory and expiratory phase and that of portal vein was 89.5% in inspiratory phase and 73.7% in expiratory phase. The positive predictability of splenic vein was 86.4% in inspiratory phase and 88.0% in expiratory phase and that of portal vein was 89.5% in inspiratory phase and 80.8% in expiratory phase. The negative predictability of splenic vein was 76.2% in inspiratory phase and 88.9% in expiratory phase and that of portal vein was 70.5% in inspiratory phase and 83.4% in expiratory phase. 6) The correlation coefficiencies between wedged hepatic venous pressure and the diameter of splenic and portal vein in control and diseased group were under 0.5, but in total the correlation coeffi